RLB Holdings and Kineta Inc. Announce Second Investment
2/6/2013 2:02:53 PM
More...
|
Kineta Inc. Adds to Its Pipeline of Venom-Derived Drug Candidates, In-licenses Conotoxin Program for Non-Narcotic Pain Relief
1/25/2013 9:31:55 AM
More...
|
Kineta Inc. Announces Regulatory Clearance to Initiate a Phase 1 Clinical Trial for ShK-186
8/21/2012 9:34:38 AM
More...
|
Kineta Inc. Pulls in $5.8 Million for Autoimmune Drug
8/14/2012 7:17:20 AM
More...
|
University of Washington, University of Texas Medical School Branch and Kineta Inc. Granted $8.1 Million for Biodefense Antiviral Drug Development
5/8/2012 9:58:18 AM
More...
|
Kineta Inc. Programs Named "Top Projects" Second Year Running
11/30/2011 9:02:31 AM
More...
|
New Funding for Kineta Inc.'s Novel Antiviral Program Targeting the Spectrum of Global Diseases
8/12/2011 10:41:39 AM
More...
|
The Iacocca Family Foundation Boosts Investment in Kineta Inc.’s Autoimmune Program
7/19/2011 9:15:08 AM
More...
|
Kineta Inc. Gets $1 M National Institutes of Health (NIH) Contract Extension
4/11/2011 12:29:12 PM
More...
|
Kineta Inc. Wins New National Institutes of Health (NIH) Contract Aimed at Speeding Development of Novel Drug Classes
10/14/2010 8:01:34 AM
More...
|
|